Presentation Information
[P2-52]Investigating the factors influencing exercerbation of disease after coinfection with influenza virus and SARS-CoV-2 and the protective role of co-vaccination
*Chimuka Handabile1,2, Marumi Ohno1,2, Toshiki Sekiya1,2,3, Yuichi Koshiishi2, Tomomi Kawakita1,2,4, Richard Obeng-Kyeremh2, Yasushi Itoh5, Naoki Nomura2, Michihito Sasaki6, Toshihiro Ito1,2, Masashi Shingai1,2,4, Hiroshi Kida1,2 (1. Institute for Vaccine Research and Development (IVReD), Hokkaido University, Sapporo, Japan (Japan), 2. Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan (Japan), 3. The Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia (Australia), 4. Division of Vaccine Immunology, Hokkaido University International Institute for Zoonosis Control, Sapporo, Japan (Japan), 5. Department of Pathology, Shiga University of Medical Science, Otsu, Japan (Japan), 6. Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan (Japan))

Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in
